Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries Limited American Depositary Shares
(NY:
TEVA
)
35.35
+0.40 (+1.14%)
Official Closing Price
Updated: 7:00 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries Limited American Depositary Shares
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
33
34
Next >
Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services
June 08, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Golden Cross Appears Before Teva Pharmaceutical Indus Investors
↗
May 27, 2022
If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
Teva, Allergan Settle Opioid Lawsuit With West Virginia
↗
May 25, 2022
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.
Via
Benzinga
Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims
May 25, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook
↗
May 03, 2022
Foreign exchange rates are weighing heavily on sales, according to the firm's CEO.
Via
Investor's Business Daily
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
↗
April 20, 2022
Via
Benzinga
Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual Meeting
May 23, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
↗
May 17, 2022
Via
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
↗
May 17, 2022
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
↗
May 17, 2022
Via
Benzinga
United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges
May 17, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
4 Analysts Have This to Say About Teva Pharmaceutical Indus
↗
May 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society 2022 Annual Meeting
May 12, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
↗
May 11, 2022
Via
Benzinga
Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure
May 10, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022
↗
May 04, 2022
Upgrades
Via
Benzinga
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
↗
May 03, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
↗
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Recap: Teva Pharmaceutical Q1 Earnings
↗
May 03, 2022
Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Teva Reports First Quarter 2022 Financial Results
May 03, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
↗
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...
Via
Benzinga
Earnings Scheduled For May 3, 2022
↗
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
May 02, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
↗
April 25, 2022
Via
Benzinga
JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters
↗
April 20, 2022
Via
Benzinga
The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study
↗
April 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM
April 19, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think?
↗
April 06, 2022
Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the advice...
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
